I-H2 i-receptor antagonists i-overdose

I-H2 receptor antagonists ngamayeza anceda ukunciphisa isisu esiswini. I-H2 i-receptor antagonist overdose yenzeka xa umntu ethatha ngaphezulu kwesiqhelo okanye isixa esinconyelwayo sonyango. Oku kunokuba ngengozi okanye ngenjongo.

Eli nqaku lelolwazi kuphela. SUKUYISETYENZISE ukunyanga okanye ukulawula ukugqithisa ngokwenyani. Ukuba wena okanye umntu onokudlulela ngaphezulu, biza inombolo yakho yongxamiseko yendawo (enje nge-911), okanye iziko lakho lendawo yetyhefu linokufikelelwa ngokuthe ngqo ngokutsalela umnxeba kwinombolo yasimahla yetyhefu (1-800-222-1222) naphi na eUnited States.

Apha ngezantsi kukho amagama eekhemikhali ezine ezichasene ne-H2. Kusenokubakho abanye.

• Cimetidine
• Iranididine
• Famotidine
• Nizatidine

Amayeza e-H2 receptor antagonist ayafumaneka ekhawuntareni nangokommiselo. Olu luhlu lunika igama elithile lamayeza kunye negama lemveliso:

• ICimetidine (iTagamet)
• IRanitidine (iZantac)
• Famotidine (iPepcid)
• Nizatidine (Axid)

Amanye amayeza anokuqulatha i-H2 receptor antagonists.

Iimpawu ze-H2 receptor antagonist overdose zezi:

• Ukubetha kwentliziyo okungaqhelekanga, kubandakanya ukubetha kwentliziyo okukhawulezayo okanye okucothayo
• Ukudideka
• Ukozela
• Urhudo
• Kunzima ukuphefumla
• Abafundi abaqaqambileyo
• Ukuhluza
• Uxinzelelo lwegazi oluphantsi
• Isicaphucaphu, ukugabha
• Intetho egudileyo
• Ukubila

Funa uncedo lwezonyango kwangoko. MUSA ukumenza umntu aphose ngaphandle kokuba ulawula ityhefu okanye umniki-nkonzo akuyalela.

Ngaba olu lwazi lukulungele:

• Ubudala bomntu, ubunzima, kunye nemeko
• Igama lemveliso (izithako kunye namandla, ukuba kuyaziwa)
• Xa yayiginyiwe
• Isixa siginyiwe

Iziko lakho lendawo yetyhefu linokufikelelwa ngokuthe ngqo ngokutsalela umnxeba wasimahla kwiNombolo yoNcedo (1-800-222-1222) naphi na eUnited States. Inombolo yomnxeba kazwelonke iya kukuvumela ukuba uthethe neengcali kwiityhefu. Baza kukunika eminye imiyalelo.

Le yinkonzo yasimahla neyimfihlo. Onke amaziko olawulo lwetyhefu aseMelika asebenzisa le nombolo yesizwe. Kuya kufuneka ubize ukuba unemibuzo malunga netyhefu okanye ukuthintela ityhefu. AKUFUNI ukuba ibe yingxakeko. Ungatsalela umnxeba nangasiphi na isizathu, iiyure ezingama-24 ngosuku, iintsuku ezisi-7 ngeveki.

Thatha isikhongozeli uhambe naso esibhedlele, ukuba kunokwenzeka.

Umboneleli uya kulinganisa kwaye abeke esweni iimpawu ezibalulekileyo zomntu, kubandakanya iqondo lobushushu, ukubetha kwentliziyo, inqanaba lokuphefumla, kunye noxinzelelo lwegazi. Iimpawu ziya kunyangwa. Umntu angafumana:

• Amalahle avuselelweyo
• Uvavanyo lwegazi kunye nomchamo
• Inkxaso yokuphefumla, kubandakanya ioksijini, ityhubhu engena emlonyeni ukuya emiphungeni, kunye nomatshini wokuphefumla (isixhobo sokuphefumla)
• I-x-ray yesifuba
• I-ECG (i-electrocardiogram, okanye ukulandelwa kwentliziyo)
• Ulwelo olungena ngaphakathi (IV)
• Laxative
• Iyeza lokunyanga iimpawu

Iingxaki ezinzima zinqabile. La ngamayeza akhuselekileyo ngokubanzi, nokuba athathwe ngeedosi ezinkulu. Uninzi lwala machiza lunokunxibelelana namanye amayeza kwaye lubangele iimpawu ezinokuba mandundu ngakumbi kunezo ze-H2 blocker zodwa.

I-H2-blocker libanda; Libethe icimetidine; Ukugqithisa kweTagamet; Ranitidine libanda; Zantac libanda; Libanda, Famotidine; Libanda yePepcid; LibandaNizatidine; Ukugqithisa kweAxid

UAronons JK. Imbali ye-H2 receptor antagonists. Ku: Aronson JK, ed. Iziphumo ebezingalindelekanga zikaMeyler zeziyobisi. Ngomhla we-16. I-Waltham, MA: Elsevier; Ngo-2016: 751-753.

Meehan TJ. Indlela yesigulana esinetyhefu. Ku: Iindonga RM, iHockberger RS, iGausche-Hill M, ii-eds. Unyango lukaRosen oluNgxamisekileyo: iikhonsepthi kunye nokuziqhelanisa neklinikhi. Umhla we-9. IPhiladelphia, PA: Elsevier; Ngo-2018: isahluko 139.